Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 104Neoplasms 11Neoplasm Metastasis 11Glioma 8Ovarian Neoplasms 6Melanoma 6Glioblastoma 6Squamous Cell Carcinoma of Head and Neck 5Liposarcoma 5Carcinoma, Non-Small-Cell Lung 5Sarcoma 4Recurrence 4Medulloblastoma 4Endometrial Neoplasms 4Diffuse Intrinsic Pontine Glioma 4Colorectal Neoplasms 4Breast Diseases 4Brain Neoplasms 4Neuroblastoma 3Neoplasms by Site 3Lymphoma 3Hereditary Sensory and Autonomic Neuropathies 3Fallopian Tube Neoplasms 3Carcinoma, Ovarian Epithelial 3Breast Neoplasms, Male 3Astrocytoma 3Triple Negative Breast Neoplasms 2Rhabdoid Tumor 2Prostatic Neoplasms 2Neoplasms, Germ Cell and Embryonal 2

Interventions

Etoposide 18Cisplatin 16Ifosfamide 14Carboplatin 14Filgrastim 12Bleomycin 12Peripheral Blood Stem Cell Transplantation 9Paclitaxel 9Radiotherapy 6etoposide phosphate 5Thiotepa 5Granulocyte Colony-Stimulating Factor 5Cyclophosphamide 4pegfilgrastim 3Mesna 3Magnetic Resonance Spectroscopy 3liposomal amphotericin B 2ixabepilone 2Vinblastine 2Therapeutics 2Temozolomide 2Specimen Handling 2Psychiatric Rehabilitation 2Oxaliplatin 2Neoadjuvant Therapy 2Immunohistochemistry 2Chemotherapy, Adjuvant 2Amifostine 2sodium thiosulfate 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Teratoma × ribociclib × Clear all
NCT02300987 2020-10-26

A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression

Novartis

Phase 2 Completed
10 enrolled 12 charts

Neoplasms, Germ Cell and Embryonal, Teratoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡